Labeled 1,N6-ethenoadenosine and 3,N4-ethenocytidine in hepatic RNA of mice given[ethyl-1,2(-3)H or ethyl-1(-14)C]ethyl carbamate (urethan).
Labeled 1,N6-ethenoadenosine and 3,N4-ethenocytidine in hepatic RNA of mice given[ethyl-1,2(-3)H or ethyl-1(-14)C]ethyl carbamate (urethan).
复制标题
给予[乙基-1,2(-3)H 或乙基-1(-14)C]乙基氨基甲酸酯(尿烷)的小鼠肝 RNA 中标记有 1,N6-乙烯基腺苷和 3,N4-乙烯基胞苷。
DOI:
10.1093/carcin/3.5.539
复制
发表时间:
1982
期刊:
影响因子:
4.7
通讯作者:
Timmins,LG
中科院分区:
文献类型:
--
作者:
Ribovich,ML;Miller,JA;Miller,EC;Timmins,LG
Injection of a single dose of [ethyl-1,2-3H] or [ethy1-1-14C]-ethyl carbamate into 12-day old male [C57BL/6 × C3H/He]F1mice or of [ethyl-1,2-3H]ethyl carbamate into adult male A/Jax mice resulted in the formation of labeled 1,N6-ethenoadenosine and 3,N4-ethenocytidine adducts in the hepatic RNA. These adducts were characterized by comigration on h.p.l.c. of3H or14C in enzymatic hydrolysates of the RNA with synthetic standards. Both the ethenoadenosine and ethenocytidine were further characterized by their conversion to acetylated products that comigrated with acetylated synthetic standards. The ethenoadenosine was also converted by anhydrous trifluoroacetic acid to a product that comigrated with synthetic 1,N6-ethenoadenine. The levels of adducts in the hepatic RNA 12 h after a single injection of 0.5–0.6 mg of ethyl carbamate/g body weight were 6–10 and 2–3 pmol/mg RNA of ethenoadenosine and ethenocytidine, respectively. No labeled ethenoadenosine or ethenocytidine could be detected in the hepatic RNA of mice given [1-14C]ethanol, an enzymatic hydrolysis product of ethyl carbamate. These data indicate that ethyl carbamate may be metabolically activated by dehydrogenation to vinyl carbamate and subsequent epoxidation of the latter compound as previously proposed. Vinyl carbamate epoxide may form etheno derivatives in a manner analogous to that demonstrated for chloroethylene oxide, an electrophilic metabolite of vinyl chloride. Vinyl carbamate has been shown to have the same spectrum of tumor induction as ethyl carbamate but to be much more active than the latter carcinogen.